On Monday, November 16, 2020, the Company, TherapeuticsMD, Inc., TXMD stock construct a change of 0 percent (Remain Flat) in a total of its share price and having its trading value $1.23, which belongs to Healthcare sector and Drug Manufacturers – Specialty & Generic industry. The company?s Market capitalization was $343.70M with the total Outstanding Shares of 272.57M.
P/S, P/E, P/B & P/C values of (NASDAQ: TXMD):
TherapeuticsMD, Inc. institutional ownership is standing at 57.9 percent, while insider ownership is 6.8 percent. As of now, TXMD has a P/S, P/E and, P/B values of 5.91, 0, and 0 respectively. Its P/Cash is valued at 4.32.
The stock SMA50 is now at -15.46 percent. In looking, the SMA 200 we see that the stock has seen a -16.53 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 77.2 percent.
Looking into the profitability ratios of TXMD stock, an investor will find its ROE, ROA, ROI standing at 310.2 percent, -83.2 percent and, -79.1 percent, respectively.
A beta factor is used to measure the volatility of the stock. The stock remaining at 10.12 percent volatile for the week and 8.1 percent for the month.
Gross / Operating Margins of TXMD:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 77.2 percent & Operating Margin seen at 0 percent.
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company TherapeuticsMD, Inc. recorded it at $0.
Historical Performance In The News:
Taking a look at the performance of TherapeuticsMD, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at -19.08 percent, resulting in a performance for the month at -25 percent.
Therefore, the stated figure displays a quarterly performance of -27.22 percent, bringing six-month performance to 10.81 percent and year to date performance of -49.17 percent. As of now, TherapeuticsMD, Inc. has a P/S, P/E and, P/B values of 5.91, 0, and 0 respectively. Its P/Cash is valued at 4.32.
Earnings per Share Details of TherapeuticsMD, Inc.:
The EPS of TXMD is strolling at -0.71, measuring its EPS growth this year at -21.3 percent. As a result, the company has an EPS growth of 53.2 percent for the approaching year.